Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3UNKNOWN 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Postoperative Complications 1Polycystic Ovary Syndrome 1Multiple Endocrine Neoplasia Type 1 1Insulin Resistance 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × Growth Hormone × Clear all
NCT03717168 2019-08-21

Effects of Growth Hormone on Difficult Ventilator Weaning Patients

National Cancer Institute, Egypt

Phase 2 Completed
60 enrolled

Postoperative Complications

NCT01853566 2014-09-03

Effects of Growth Hormone Administration on Muscle Strength and Body Composition in Men Over 50 Years Old

Universidade Federal do Rio de Janeiro

Phase 4 Completed
13 enrolled
Endocrine

Multiple Endocrine Neoplasia Type 1

NCT00518635 2013-02-20

Low Dose Growth Hormone in Obese PCOS Women

Oregon Health and Science University

Phase NA Withdrawn

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡